Our research focuses on the large scale study of fundamental questions in cancer genomics and metabolism. It is computational in its nature and translational in its goals. We collaborate with many leading experimental cancer labs in the US and Europe, aiming to identify new ways to advance precision oncology and predict new drug targets and cancer biomarkers.